• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Is chewed raltegravir an option to care for HIV-infected patients with active tuberculosis?

作者信息

Gervasoni Cristina, Riva Agostino, Impagnatiello Caterina, Galli Massimo, Cattaneo Dario

出版信息

Clin Infect Dis. 2013 Aug;57(3):480-1. doi: 10.1093/cid/cit258. Epub 2013 Apr 24.

DOI:10.1093/cid/cit258
PMID:23616494
Abstract
摘要

相似文献

1
Is chewed raltegravir an option to care for HIV-infected patients with active tuberculosis?咀嚼式拉替拉韦是否可作为治疗合并活动性结核病的HIV感染患者的一种选择？
Clin Infect Dis. 2013 Aug;57(3):480-1. doi: 10.1093/cid/cit258. Epub 2013 Apr 24.
2
Clinical experience of raltegravir-containing regimens in HIV-infected patients during rifampicin-containing treatment of tuberculosis.在接受含利福平治疗结核病的HIV感染患者中使用含拉替拉韦方案的临床经验。
J Antimicrob Chemother. 2011 Apr;66(4):951-2. doi: 10.1093/jac/dkq540. Epub 2011 Jan 22.
3
Pharmacokinetics of double-dose raltegravir in two patients with HIV infection and tuberculosis.
AIDS. 2010 Jan 16;24(2):328-30. doi: 10.1097/QAD.0b013e3283350f08.
4
Effect of concomitantly administered rifampin on the pharmacokinetics and safety of atazanavir administered twice daily.同时服用利福平对每日两次给药的阿扎那韦药代动力学及安全性的影响。
Antimicrob Agents Chemother. 2007 Sep;51(9):3104-10. doi: 10.1128/AAC.00341-07. Epub 2007 Jun 18.
5
Pharmacokinetic interaction of rifapentine and raltegravir in healthy volunteers.利福喷汀与拉替拉韦在健康志愿者中的药代动力学相互作用。
J Antimicrob Chemother. 2014 Apr;69(4):1079-85. doi: 10.1093/jac/dkt483. Epub 2013 Dec 15.
6
Systemic exposure to rifampicin in patients with tuberculosis and advanced HIV disease during highly active antiretroviral therapy in Burkina Faso.在布基纳法索进行高效抗逆转录病毒治疗期间，肺结核和晚期 HIV 病患者体内利福平的全身暴露情况。
J Antimicrob Chemother. 2012 Feb;67(2):469-72. doi: 10.1093/jac/dkr445. Epub 2011 Oct 25.
7
Pharmacokinetics of nevirapine in HIV and tuberculosis-coinfected children receiving antiretroviral fixed-dose combination tablets while receiving rifampicin-containing tuberculosis treatment and after rifampicin discontinuation.奈韦拉平在 HIV 和结核分枝杆菌双重感染儿童中的药代动力学：接受含利福平的结核治疗和利福平停药后，接受抗逆转录病毒固定剂量复方片剂治疗时的情况。
Pediatr Infect Dis J. 2012 Apr;31(4):389-91. doi: 10.1097/INF.0b013e3182401c41.
8
Nevirapine levels after discontinuation of rifampicin therapy and 60-week efficacy of nevirapine-based antiretroviral therapy in HIV-infected patients with tuberculosis.利福平治疗中断后奈韦拉平的血药浓度及基于奈韦拉平的抗逆转录病毒疗法对合并结核病的HIV感染患者的60周疗效
Clin Infect Dis. 2007 Jan 1;44(1):141-4. doi: 10.1086/510078. Epub 2006 Nov 21.
9
Lopinavir exposure is insufficient in children given double doses of lopinavir/ritonavir during rifampicin-based treatment for tuberculosis.在基于利福平的抗结核治疗期间，给儿童双倍剂量的洛匹那韦/利托那韦，洛匹那韦的暴露量不足。
Antivir Ther. 2011;16(3):417-21. doi: 10.3851/IMP1757.
10
Effect of intermittent rifampicin on the pharmacokinetics and safety of raltegravir.间断利福平对拉替拉韦的药代动力学及安全性的影响。
J Antimicrob Chemother. 2015 Feb;70(2):550-4. doi: 10.1093/jac/dku376. Epub 2014 Sep 26.

引用本文的文献

1
Pharmacokinetics of chewed vs. swallowed raltegravir in a patient with AIDS and MAI infection: some new conflicting data.艾滋病和巨细胞病毒感染患者中咀嚼与吞咽瑞替拉韦的药代动力学：一些新的矛盾数据。
AIDS Res Ther. 2015 Jan 17;12(1):1. doi: 10.1186/s12981-014-0041-8. eCollection 2015.